Ecological and immunological determinants of influenza evolution

被引:506
作者
Ferguson, NM
Galvani, AP
Bush, RM
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England
[2] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA
[3] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA
基金
美国国家卫生研究院; 中国国家自然科学基金; 美国国家科学基金会;
关键词
D O I
10.1038/nature01509
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In pandemic and epidemic forms, influenza causes substantial, sometimes catastrophic, morbidity and mortality. Intense selection from the host immune system drives antigenic change in influenza A and B, resulting in continuous replacement of circulating strains with new variants able to re-infect hosts immune to earlier types. This 'antigenic drift'(1) often requires a new vaccine to be formulated before each annual epidemic. However, given the high transmissibility and mutation rate of influenza, the constancy of genetic diversity within lineages over time is paradoxical. Another enigma is the replacement of existing strains during a global pandemic caused by 'antigenic shift'-the introduction of a new avian influenza A subtype into the human population(1). Here we explore ecological and immunological factors underlying these patterns using a mathematical model capturing both realistic epidemiological dynamics and viral evolution at the sequence level. By matching model output to phylogenetic patterns seen in sequence data collected through global surveillance(2), we find that short-lived strain-transcending immunity is essential to restrict viral diversity in the host population and thus to explain key aspects of drift and shift dynamics.
引用
收藏
页码:428 / 433
页数:7
相关论文
共 29 条
  • [11] VARIATION IN FREQUENCY OF NATURAL REINFECTION WITH INFLUENZA-A VIRUSES
    FRANK, AL
    TABER, LH
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1983, 12 (01) : 17 - 23
  • [12] NATURALLY ACQUIRED-IMMUNITY TO INFLUENZA TYPE-A - FURTHER PROSPECTIVE-STUDY
    GILL, PW
    MURPHY, AM
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1977, 2 (23) : 761 - 765
  • [13] Glezen W.P., 1997, VIRAL INFECT HUMANS, P473
  • [14] HOSKINS TW, 1979, LANCET, V1, P33
  • [15] A global lab against influenza
    Layne, SP
    Beugelsdijk, TJ
    Patel, CKN
    Taubenberger, JK
    Cox, NJ
    Gust, ID
    Hay, AJ
    Tashiro, M
    Lavanchy, D
    [J]. SCIENCE, 2001, 293 (5536) : 1729 - 1729
  • [16] Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: Multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes
    Lindstrom, SE
    Hiromoto, Y
    Nishimura, H
    Saito, T
    Nerome, R
    Nerome, K
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (05) : 4413 - 4426
  • [17] VACCINE-RELATED DETERMINANTS OF THE INTERLEUKIN-2 RESPONSE TO INFLUENZA VACCINATION IN HEALTHY-YOUNG AND ELDERLY ADULTS
    MCELHANEY, JE
    MENEILLY, GS
    PINKOSKI, MJ
    LECHELT, KE
    BLEACKLEY, RC
    [J]. VACCINE, 1995, 13 (01) : 6 - 10
  • [18] MOSER MR, 1979, AM J EPIDEMIOL, V110, P1
  • [19] Nicholson KG, 1998, TXB INFLUENZA
  • [20] Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function
    Sambhara, S
    Kurichh, A
    Miranda, R
    Tumpey, T
    Rowe, T
    Renshaw, M
    Arpino, R
    Tamane, A
    Kandil, A
    James, O
    Underdown, B
    Klein, M
    Katz, J
    Burt, D
    [J]. CELLULAR IMMUNOLOGY, 2001, 211 (02) : 143 - 153